Pharmaceutical Raw Materials Manufacturing in China

IBISWorld Industry Report

Publication Date	June 2009
Publisher	IBISWorld
Product Type	Report
Pages	48
ISBN Number	not applicable
Product Code	IBI01570

Buy this product or for assistance call +44 20 7060 7474

PDF £375.00$624 | €420

FAX Order above formats by FAX

Summary

The IBISWorld Pharmaceutical Raw Materials Manufacturing in China industry report is comprised of establishments primarily engaged in the manufacture of chemical medicine raw materials for further manufacture of finished pharmaceutical products. This industry is within the Chemical Pharmaceutical Manufacturing sub-sector in China, which includes the manufacture of chemical substances for pharmacy, such as bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. However, hematic products are not included. This industry acts as a bridge between the upstream chemical industry and the downstream medical market, and is affected not only by the economy and trade, but also by medical insurance levels of China.

Content

Industry Definition
- Activities (Products and Services)
- Similar Industries
- Other Related Industries
Key Statistics
- Current Prices
- Constant Prices
- Real Growth
- Ratio Table
Segmentation
- Products and Service Segmentation
- Major Market Segments
- Industry Concentration
- Geographic Spread
Market Characteristics
- Market Size
- Linkages
- Demand Determinants
- Domestic and International Markets
- Basis of Competition
- Life Cycle
Industry Conditions
- Barriers to Entry
- Taxation
- Industry Assistance ;Regulation and Deregulation
- Cost Structure
- Capital and Labor Intensity
- Technology and Systems
- Industry Volatility
- Globalization
Key Factors
- Key Sensitivities
- Key Success Factors
Key Competitors
- Major Players
- Player Performance
- Other Players
Industry Performance
- Current Performance
- Historical Performance
Outlook